Abstract: An anti-diarrhea composition comprises diarrhea symptom-reducing amounts of a powdered absorptive material capable of absorbing pathogenic intestinal bacteria, a sodium salt, a potassium salt and a sugar. The absorptive material may be Smectite or mormoiron attapulgite. The salts are preferably NaCl and KCl, with NaHCO.sub.3 also being present. Suitable sugars are glucose and dextrose. The composition may also contain a suspending agent, a coloring agent, a flavoring agent and a sweetening agent. It may be packaged in solid form for admixture with water prior to administration and is preferably moisture protected, for example by the nature of the packaging or by inclusion of a dessicant. The absorptive material may be packaged separately from the salts and sugar. On admixture with water for adminstration, the composition preferably contains, per liter, 2.5 to 15 g of absorptive material, 10 to 30 g of glucose, 60 to 120 mEq of Na.sup.+, 10 to 50 mEq of HCO.sup.- and 10 to 30 mEq of K.sup.+.
Type:
Grant
Filed:
August 29, 1988
Date of Patent:
July 17, 1990
Assignee:
Societe de Conseils de Recherches et d'Applications Scientifiques (S. C. A. S.)
Abstract: This invention relates to compositions comprising electrolytes dissolved in a buffer which is painless when administered by irrigation.This invention also relates to compositions comprising a local anesthetic such as lidocaine, procaine, mepivacaine or marcaine, dissolved in a buffered solution containing salts which do not cause pain when the solutions are administered. The compositions are useful for administration as painless local anesthetics and painless irrigation-anesthetizing solutions for human and animal use. The invention further relates to methods for painless irrigation of wounds and of inducing painless local anesthesia comprising administering an effective amount of the compositions of this invention to an animal.
Abstract: An organ preservation solution, particularly valuable in the preservation of mammalian hearts intended for transplantation, in aqueous solution, at least about 3% by weight of polypropylene glycol having an average molecular weight of at least about 15,000 daltons and being free of material retained by 10 micron filtration, a buffer buffering the pH of the solution perfusate to a value in the range of about 7.1 to about 7.5, and an impermeant composition for retarding the passage of water across cell membranes of an organ treated with the solution.
Abstract: A blood substitute suitable for replacing blood in mammalian subjects when performance of surgical procedures at hypothermic temperatures is described. The blood substitute comprises water, electrolytes at physiological concentration, dextran 40 at a concentration sufficient for the blood substitute to achieve a colloidal suspension having a fluid osmotic pressure essentially equivalent to mammalian plasma, HEPES buffer at a physiological pH, dextrose, magnesium ion at a concentration of about 0.01M and potassium ion at a concentration greater than 10 mEq per liter sufficient to prevent or arrest cardiac fibrillation. In one embodiment the blood substitute is a multi-solution system wherein the solutions comprise differing levels of the above-indicated componants and are administered sequentially to completely replace a subjects circulating blood.
Type:
Grant
Filed:
April 26, 1989
Date of Patent:
May 8, 1990
Assignee:
Cryomedical Sciences Inc.
Inventors:
Paul E. Segall, Harold D. Waitz, Hal Sternberg
Abstract: A composition and method of use for the treatment of pain and inflammation associated with dental disease is disclosed. The composition comprises pine resin and salt in a 1:1-5 parts by weight relationship which is prepared by mixing the pine resin and salt, heating the mixture while stirring, cooling and grinding the resulting solid to a powder form.
Type:
Grant
Filed:
November 10, 1988
Date of Patent:
April 24, 1990
Inventors:
Hae-chul Park, Young-cha Choi, Kyung-dong Park, Mi-ae Park, Kyu-dong Park
Abstract: A physiologically acceptable solution which is both hyperosmotic and hyperoncotic with respect to blood plasma and has utility in treating patients experiencing or threatening to experience hypodynamic shock. The physiologically acceptable solution comprises a hyperosmotic concentration of a crystalloid (in excess of about 1800 mOsms) and hyperoncotic concentration of a colloid (in excess of about 30 mm Hg). The physiologically acceptable solution is easily administered by single, rapid infusion of approximately 4 to 5 ml/kg of body weight and results in a rapid and sustained normalization of circulatory function.
Type:
Grant
Filed:
February 24, 1988
Date of Patent:
March 13, 1990
Assignee:
The Regents of the University of California
Abstract: A pelletized feed supplement is supplied which effectively increases productivity of animals fed high acid producing diets. The pelletized feed supplement can also be used to neutralize stomach acid of humans and to maintain a proper electrolyte balance. A method is taught of producing the pelletized feed supplement which results in a buffering agent which is dissolved gradually, and has a high buffering capacity.
Abstract: A dialytic solution for peritoneal dialysis, which dialytic solution is characterized by containing glycerol and a monosaccharide as osmotic pressure regulating agents for regulating the osmotic pressure to a level necessary for the removal of water.
Abstract: A flavored and sweetened aqueous beverage which rapidly rehydrates dehydrated individuals, containing specified amounts of water, sodium chloride, citric acid and APM.
Type:
Grant
Filed:
July 23, 1986
Date of Patent:
October 17, 1989
Assignee:
General Foods Corp.
Inventors:
Peter C. Boyle, Daniel G. Steffen, John L. Melton, Gus D. Coccodrilli, Jr., Michael A. Nagy
Abstract: A unique, chemically-defined nutrient composition is disclosed which can enable stressed, catabolic, marathon athletes to achieve superior performance. The diet provides substantially all of the essential nutrients along with flavoring aids in simple, readily available form and comprises free amino acids, vitamins, minerals and trace elements, electrolytes, simple and complex carbohydrates, and flavoring aids. This diet benefits athletes because it provides for substantially all of the nutritional requirements, allows for reproducibility and user familiarity through precise chemical definition, supplies optimal nutritional requirements during training and competition through unique tailoring to the nutritional requirements of an individual athlete, requires minimal digestive energy, and encourages maximal absorption of nutrients. A specific mixture of amino acids, carbohydrates, and flavoring aids is used to achieve superior taste.
Abstract: A fitness drink powder comprising as main ingredients long chain glucose polymer, sodium chloride, sodium bicarbonate, magnesium chloride and fruit acid.Said fitness drink powder may also contain a sweetener and aromas and colourings.A drink prepared from said fitness drink powder has a pH of 5.2 to 5.8.
Abstract: Decubitus ulcers are treated with a preconditioning aqueous medium and then with a non-systemic basic ointment. The aqueous medium comprises an aqueous solution of pyridoxine hydrochloride, zinc chloride, dextrose, ethanol and sodium chloride, with a trace of phenyl mercuric nitrate N.F., and has a pH in the range of 4.3 to 6.8 so as to facilitate ionization of naturally occurring amino acids at the wound site. The ointment comprises calcium carbonate, magnesium hydroxide, aluminum hydroxide, zinc chloride, sodium chloride, anhydrous lanolin, hydrophilic ointment and vitamin A and has a pH in the range of from about 6.5 to 9.0 so as to facilitate chelation of the amino acid and zinc ions and enhance tissue repair.
Abstract: Halophors, e.g., bromophors, comprising a complex of sulfone, e.g., sulfolane, halide ion, e.g., sodium bromide, and halogen, e.g., bromine, are described. Solid, free-flowing halophor compositions of the aforesaid complex and an amorphous siliceous carrier are also described.
Type:
Grant
Filed:
January 16, 1986
Date of Patent:
July 4, 1989
Assignee:
PPG Industries, Inc.
Inventors:
Robert H. Juda, Paritosh M. Chakrabarti, Roger A. Crawford